Drug Shortage Report for DANTRIUM INTRAVENOUS
Report ID | 166508 |
Drug Identification Number | 01997572 |
Brand name | DANTRIUM INTRAVENOUS |
Common or Proper name | DANTROLENE SODIUM |
Company Name | ENDO OPERATIONS LTD. |
Market Status | MARKETED |
Active Ingredient(s) | DANTROLENE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 6x20mg Vials |
ATC code | M03CA |
ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-20 |
Estimated end date | 2022-11-04 |
Actual end date | 2022-12-21 |
Shortage status | Resolved |
Updated date | 2022-12-23 |
Company comments | Limited quantity available on allocation under October, distributed by Paladin Labs PaladinCS@endo.com |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-12-23 | French | Compare |
v7 | 2022-12-23 | English | Compare |
v6 | 2022-10-06 | French | Compare |
v5 | 2022-10-06 | English | Compare |
v4 | 2022-08-11 | French | Compare |
v3 | 2022-08-11 | English | Compare |
v2 | 2022-08-11 | French | Compare |
v1 | 2022-08-11 | English | Compare |
Showing 1 to 8 of 8